dc.contributor.advisor | Giraldo Balderrama Leonard Jesús | |
dc.contributor.author | Nazario Encarnación, Miriam Carolina | |
dc.date.accessioned | 2024-02-16T15:09:55Z | |
dc.date.available | 2024-02-16T15:09:55Z | |
dc.date.issued | 2022-06-03 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12970/2003 | |
dc.description.abstract | Objetivo: principal de este estudio fue determinar cómo los
factores asociados inciden en la automedicación con
azitromicina como tratamiento de COVID-19 en
establecimientos farmacéuticos del Rímac 2020. Materiales y
métodos: se utilizó la técnica de recopilación de datos
mediante una encuesta anónima estructurada con preguntas
cerradas Resultados: se obtuvieron utilizando el programa SPSS
24.0 IBM para Windows Microsoft, Excel, descriptivo
considerando la frecuencia de respuesta para cada ítem con
una población 56% femenina y 46% masculino con rango de 18
a 73 años. El 72.5% de sujetos de estudio adquirieron
medicamentos sin receta médica en establecimiento
farmacéutico del distrito del RIMAC. El 59.5% indico conocer el
riesgo del uso inadecuado del medicamento y 58.5% conocía
acerca de la resistencia antimicrobiana del consumo de
antibiótico si no lo requiere. La respuesta negativa es
predominante en los ítems 2, 3, 4, 7 y 8. Ante las preguntas si
tomaron azitromicina por prevención de la enfermedad COVID-
19 el 62.5% y un 60.5% indico que no tomo azitromicina ante
sospecha de padecer de la enfermedad COVID-19, En
comparación de un 39.5 % que si tomo azitromicina y un 30%
recomendó a un familiar el 35.5% que si compro en un
establecimiento farmacéutico. Conclusiones: Considerando los
factores observamos que el 72.5% si logra comprar
medicamentos sin receta médica y un 39.5% si tomo
azitromicina ante la sospecha de padecer la enfermedad de
COVID-19. | es_PE |
dc.description.abstract | Objective of this study was to determine how the associated
factors affect self-medication with azithromycin as a treatment for
COVID-19 in the pharmacies and pharmacies of the Rimac district in
2020. Materials and methods: the data collection technique was
used through a structured anonymous survey with closed questions
Results: they were obtained using the SPSS 24.0 IBM program for
Microsoft Windows, Excel, descriptive considering the response
frequency for each item with a population of 56% female and 46%
male with a range of 18 to 73 years. 72.5% of the study subjects
acquired medications without a prescription in drugstores and
pharmacies in the RIMAC district. 59.5% indicated knowing the risk
of inappropriate use of the medication and 58.5% knew about the
antimicrobial resistance of antibiotic consumption if it is not
required. the negative answer is predominant in items 2, 3, 4, 7 and
8. When asked if they took azithromycin for prevention of COVID-
19 disease, 62.5% and 60.5% indicated that they did not take
azithromycin due to suspicion of suffering from the disease. COVID-
19 disease, compared to 39.5% that if I take azithromycin and 30%
recommended to a family member 35.5% that if I buy in a
pharmaceutical establishment. Conclusions: Considering the
factors we observe that 72.5% if they manage to buy medicines
without a prescription and 39.5% if I take azithromycin when
suspected of having COVID-19 disease. | es_PE |
dc.format | application/pdf | es_PE |
dc.language.iso | spa | es_PE |
dc.publisher | Universidad María Auxiliadora | es_PE |
dc.rights | info:eu-repo/semantics/openAccess | es_PE |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | es_PE |
dc.subject | Automedicación | es_PE |
dc.subject | Azitromicina | es_PE |
dc.subject | Factores | es_PE |
dc.subject | Covid-19 | es_PE |
dc.subject | Self-medication | es_PE |
dc.subject | Azithromycin | es_PE |
dc.subject | Factors | es_PE |
dc.subject | Covid-19 | es_PE |
dc.title | Factores asociados a la automedicación con azitromicina como tratamiento al sars-cov-2 en establecimientos farmacéuticos en el distrito del Rimac-2020 | es_PE |
dc.title.alternative | Factors associated with self-medication with azithromycin as treatment of sars-cov-2 in pharmaceutical establishments in the Rimac district-2020 | es_PE |
dc.type | info:eu-repo/semantics/bachelorThesis | es_PE |
dc.publisher.country | PE | es_PE |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.01.05 | es_PE |
dc.type.version | info:eu-repo/semantics/acceptedVersion | es_PE |
thesis.degree.discipline | Farmacia y Bioquímica | es_PE |
thesis.degree.grantor | Universidad María Auxiliadora. Facultad de Ciencias de la Salud. | es_PE |
thesis.degree.name | Químico Farmacéutico | es_PE |
renati.advisor.dni | 10728715 | |
renati.advisor.orcid | https://orcid.org/0000-0001-9953-0957 | es_PE |
renati.author.dni | 08163348 | |
renati.discipline | 917046 | es_PE |
renati.juror | Rodríguez Lichtenheldt, José Edwin Adalberto | |
renati.juror | Velarde Apaza, Leslie Diana | |
renati.juror | La Serna La Rosa, Pablo Antonio | |
renati.level | https://purl.org/pe-repo/renati/level#tituloProfesional | es_PE |
renati.type | https://purl.org/pe-repo/renati/type#tesis | es_PE |